Measuring and Modelling the Epithelial- Mesenchymal Hybrid State in Cancer: Clinical Implications
- 26 April 2021
- journal article
- review article
- Published by S. Karger AG in Cells Tissues Organs
- Vol. 211 (2) , 110-133
Abstract
The epithelial-mesenchymal (E/M) hybrid state has emerged as an important mediator of elements of cancer progression, facilitated by epithelial mesenchymal plasticity (EMP). We review here evidence for the presence, prognostic significance, and therapeutic potential of the E/M hybrid state in carcinoma. We further assess modelling predictions and validation studies to demonstrate stabilised E/M hybrid states along the spectrum of EMP, as well as computational approaches for characterising and quantifying EMP phenotypes, with particular attention to the emerging realm of single-cell approaches through RNA sequencing and protein-based techniques.Keywords
All Related Versions
This publication has 152 references indexed in Scilit:
- An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor ResistanceClinical Cancer Research, 2013
- A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomasDiagnostic Pathology, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal MarkersMolecular Cancer Research, 2011
- An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transitionMolecular Biology of the Cell, 2011
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypesProceedings of the National Academy of Sciences, 2010
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- Phenotypic evaluation of the basal-like subtype of invasive breast carcinomaLaboratory Investigation, 2005
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000